Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MicroIskin: Cutaneous Penetration of Polymeric Microparticles in Atopic Dermatitis
NCT02369432Phase 1Terminated
- Sponsor
- CHU de Besançon
- Start
- Feb 2015
- Primary completion
- Oct 2017
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial in atopic dermatitis (AD), sponsored by CHU de Besançon. Primary endpoint: Assessment of the penetration beyond the stratum corneum in human skin at Day 3. Started Feb 2015; status: terminated.
02
Conditions
atopic dermatitis (AD)
Beyond the preview
Go deeper on NCT02369432.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02369432.